LogicBio Therapeutics, Inc. Patent Applications Rejected
1 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-02-23: Application 18686362; Invention AAV PARTICLES COMPRISING LIVER-TROPIC CAPSID PROTEIN AND ACID ALPHA-GLUCOSIDASE AND USE TO TREAT POMPE DISEASE; Applicant LogicBio Therapeutics, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | 18686362 | AAV PARTICLES COMPRISING LIVER-TROPIC CAPSID PROTEIN AND ACID ALPHA-GLUCOSIDASE AND USE TO TREAT POMPE DISEASE | LogicBio Therapeutics, Inc. CANbridge Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20260131031A1 | Yunxiang Zhu Peter Pechan Anannya Banga | United States United States United States |